Eddit
K |
|||
Zeile 28: | Zeile 28: | ||
{{tp|p=32161940|t=ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China |pdf=|usr=}} | {{tp|p=32161940|t=ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China |pdf=|usr=}} | ||
{{tp|p=32280952|t=ä. Good IgA bad IgG in SARS-CoV-2 infection?|pdf=|usr=}} | {{tp|p=32280952|t=ä. Good IgA bad IgG in SARS-CoV-2 infection?|pdf=|usr=}} | ||
− | + | {{tp|p=32354367|t=2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia |pdf=|usr=}} | |
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
Zeile 40: | Zeile 40: | ||
{{tp|p=32358954|t=ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing |pdf=|usr=}} | {{tp|p=32358954|t=ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing |pdf=|usr=}} | ||
{{tp|p=32361747|t=ä. COVID-19, superinfections and antimicrobial development: What can we expect?|pdf=|usr=}} | {{tp|p=32361747|t=ä. COVID-19, superinfections and antimicrobial development: What can we expect?|pdf=|usr=}} | ||
+ | {{tp|p=32188484|t=2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan |pdf=|usr=}} | ||
+ | {{tp|p=32345311|t=2020. Clinical determinants for fatality of 44,672 patients with COVID-19 |pdf=|usr=}} | ||
Zeile 46: | Zeile 48: | ||
{{tp|p=32161968|t=ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias |pdf=|usr=}} | {{tp|p=32161968|t=ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias |pdf=|usr=}} | ||
{{tp|p=32271373|t=ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia |pdf=|usr=}} | {{tp|p=32271373|t=ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32375845|t=2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?|pdf=|usr=}} | ||
+ | |||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
{{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}} | {{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}} | ||
+ | {{tp|p=32357997|t=2020. Coagulopathy associated with COVID-19 |pdf=|usr=}} | ||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
Zeile 60: | Zeile 65: | ||
{{tp|p=32357210|t=ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19) |pdf=|usr=}} | {{tp|p=32357210|t=ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19) |pdf=|usr=}} | ||
{{tp|p=32215618|t=ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study |pdf=|usr=}} | {{tp|p=32215618|t=ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study |pdf=|usr=}} | ||
− | + | {{tp|p=32323704|t=2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis |pdf=|usr=}} | |
+ | {{tp|p=32266761|t=2020. Neurological manifestations in COVID19 caused by SARS-CoV?2 |pdf=|usr=}} | ||
+ | {{tp|p=32354654|t=ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic |pdf=|usr=}} | ||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
+ | {{tp|p=32371006|t=ä. Diarrhea: An underestimated symptom in Coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32360055|t=ä. Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32305249|t=ä. A case of COVID-19 patient with the diarrhea as initial symptom and literature review |pdf=|usr=}} | ||
+ | {{tp|p=32366282|t=2020. Liver injury in critically ill patients with COVID-19: a case series |pdf=|usr=}} | ||
Zeile 80: | Zeile 91: | ||
{{tp|p=32327229|t=2020. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type |pdf=|usr=}} | {{tp|p=32327229|t=2020. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type |pdf=|usr=}} | ||
{{tp|p=32331781|t=ä. Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT |pdf=|usr=}} | {{tp|p=32331781|t=ä. Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT |pdf=|usr=}} | ||
+ | {{tp|p=32355659|t=ä. The role of 18F-FDG PET for COVID-19 infection: myth versus reality |pdf=|usr=}} | ||
+ | {{tp|p=32295762|t=2020. Chest CT imaging of an early Canadian case of COVID-19 in a 28-year-old man |pdf=|usr=}} | ||
+ | {{tp|p=32312827|t=2020. Lung ultrasonography in a woman with COVID-19: This examination could be remote |pdf=|usr=}} | ||
+ | {{tp|p=32375883|t=2020. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis |pdf=|usr=}} | ||
+ | {{tp|p=32234724|t=2020. Lung ultrasound findings in a 64-year-old woman with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32345353|t=2020. Lung ultrasound findings in patients with COVID-19 pneumonia |pdf=|usr=}} | ||
+ | |||
Zeile 89: | Zeile 107: | ||
{{tp|p=32216961|t=2020. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area |pdf=|usr=}} | {{tp|p=32216961|t=2020. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area |pdf=|usr=}} | ||
{{tp|p=32321645|t=ä. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update |pdf=|usr=}} | {{tp|p=32321645|t=ä. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update |pdf=|usr=}} | ||
− | + | {{tp|p=32328954|t=ä. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice |pdf=|usr=}} | |
+ | {{tp|p=32321116|t=2020. COVID-19 Diagnostic and Management Protocol for Pediatric Patients |pdf=|usr=}} | ||
+ | {{tp|p=32350002|t=2020. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline |pdf=|usr=}} | ||
+ | {{tp|p=32312828|t=2020. Clarifying the role of lung ultrasonography in COVID-19 respiratory disease |pdf=|usr=}} | ||
+ | {{tp|p=32375855|t=2020. Ethics guidelines on COVID-19 triage?an emerging international consensus |pdf=|usr=}} | ||
+ | {{tp|p=32234064|t=2020. Covid-19 in China: ten critical issues for intensive care medicine |pdf=|usr=}} | ||
+ | {{tp|p=32188482|t=2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China |pdf=|usr=}} | ||
+ | {{tp|p=32151274|t=2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore |pdf=|usr=}} | ||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
{{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32357995|t=2020. Tracheal intubation in patients with COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
Zeile 98: | Zeile 125: | ||
{{tp|p=32161990|t=ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China |pdf=|usr=}} | {{tp|p=32161990|t=ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China |pdf=|usr=}} | ||
{{tp|p=32328736|t=ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity |pdf=|usr=}} | {{tp|p=32328736|t=ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity |pdf=|usr=}} | ||
+ | {{tp|p=32376643|t=2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women |pdf=|usr=}} | ||
+ | {{tp|p=32332039|t=2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32357998|t=2020. Cardiac considerations in patients with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32332038|t=2020. Asthma and COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32264922|t=2020. COVID-19 and the RAAS?a potential role for angiotensin II?|pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
Zeile 104: | Zeile 138: | ||
{{tp|p=32211789|t=ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area |pdf=|usr=}} | {{tp|p=32211789|t=ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area |pdf=|usr=}} | ||
{{tp|p=32240285|t=ä. First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States ? Maricopa County, Arizona, 2020 |pdf=|usr=}} | {{tp|p=32240285|t=ä. First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States ? Maricopa County, Arizona, 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32332041|t=2020. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission |pdf=|usr=}} | ||
+ | {{tp|p=32317275|t=2020. SARS-CoV-2 infection associated with spontaneous pneumothorax |pdf=|usr=}} | ||
Zeile 109: | Zeile 145: | ||
{{tp|p=32251842|t=ä. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital |pdf=|usr=}} | {{tp|p=32251842|t=ä. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital |pdf=|usr=}} | ||
{{tp|p=32359867|t=ä. Impact of gender on extent of lung injury in COVID-19 |pdf=|usr=}} | {{tp|p=32359867|t=ä. Impact of gender on extent of lung injury in COVID-19 |pdf=|usr=}} | ||
− | + | {{tp|p=32362344|t=ä. Association between clinical manifestations and prognosis in patients with COVID-19 |pdf=|usr=}} | |
+ | {{tp|p=32078069|t=2020. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies |pdf=|usr=}} | ||
+ | {{tp|p=32375850|t=2020. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan |pdf=|usr=}} | ||
+ | {{tp|p=32354360|t=2020. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China |pdf=|usr=}} | ||
Zeile 119: | Zeile 158: | ||
{{tp|p=32360083|t=ä. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients |pdf=|usr=}} | {{tp|p=32360083|t=ä. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients |pdf=|usr=}} | ||
{{tp|p=32306288|t=ä. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties |pdf=|usr=}} | {{tp|p=32306288|t=ä. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties |pdf=|usr=}} | ||
+ | {{tp|p=32277367|t=ä. Rheumatologists? perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets |pdf=|usr=}} | ||
+ | {{tp|p=32373721|t=2020. Low dose lung radiotherapy for COVID-19 pneumonia The rationale for a cost-effective anti-inflammatory treatment |pdf=|usr=}} | ||
+ | {{tp|p=32269021|t=2020. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection |pdf=|usr=}} | ||
+ | {{tp|p=32209231|t=2020. Computers and viral diseases Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |pdf=|usr=}} | ||
+ | {{tp|p=32264963|t=2020. A new clinical trial to test high-dose vitamin C in patients with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32280433|t=ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model |pdf=|usr=}} | ||
+ | {{tp|p=32345336|t=2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 |pdf=|usr=}} | ||
+ | |||
Zeile 131: | Zeile 178: | ||
{{tp|p=32315026|t=ä. Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems |pdf=|usr=}} | {{tp|p=32315026|t=ä. Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems |pdf=|usr=}} | ||
{{tp|p=32166318|t=ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response |pdf=|usr=}} | {{tp|p=32166318|t=ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response |pdf=|usr=}} | ||
+ | {{tp|p=32354653|t=ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice |pdf=|usr=}} | ||
+ | |||
+ | |||
* | * | ||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
Zeile 152: | Zeile 202: | ||
{{tp|p=32291080|t=ä. Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience |pdf=|usr=}} | {{tp|p=32291080|t=ä. Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience |pdf=|usr=}} | ||
{{tp|p=32299617|t=2020. Respirators and surgical facemasks for COVID-19: implications for MRI |pdf=|usr=}} | {{tp|p=32299617|t=2020. Respirators and surgical facemasks for COVID-19: implications for MRI |pdf=|usr=}} | ||
− | + | {{tp|p=32235170|t=ä. Triaging Spine Surgery in the COVID-19 Era |pdf=|usr=}} | |
+ | {{tp|p=32274425|t=2020. COVID-19: Global radiation oncology?s targeted response for pandemic preparedness |pdf=|usr=}} | ||
+ | {{tp|p=32321117|t=2020. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance |pdf=|usr=}} | ||
+ | {{tp|p=32294673|t=2020. How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center |pdf=|usr=}} | ||
+ | {{tp|p=32376644|t=2020. Confronting the COVID-19 surgery crisis: time for transformational change |pdf=|usr=}} | ||
+ | {{tp|p=32152059|t=2020. Proposed protocol to keep COVID-19 out of hospitals |pdf=|usr=}} | ||
+ | {{tp|p=32269020|t=2020. Projecting demand for critical care beds during COVID-19 outbreaks in Canada |pdf=|usr=}} | ||
+ | {{tp|p=32317277|t=2020. Redesign of a rural emergency department to prepare for the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32336679|t=2020. Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions |pdf=|usr=}} | ||
+ | {{tp|p=32273245|t=ä. The COVID-19 pandemic: Important considerations for contact lens practitioners |pdf=|usr=}} | ||
+ | {{tp|p=32359967|t=ä. Increased risk of ocular injury seen during lockdown due to COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32336578|t=ä. Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?|pdf=|usr=}} | ||
+ | {{tp|p=32272172|t=2020. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?|pdf=|usr=}} | ||
+ | {{tp|p=32334933|t=ä. Contact lens wear during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32305289|t=ä. No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond??? |pdf=|usr=}} | ||
+ | {{tp|p=32183864|t=2020. Safe patient transport for COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32070391|t=2020. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China |pdf=|usr=}} | ||
+ | {{tp|p=32264974|t=2020. Practice of novel method of bedside postpyloric tube placement in patients with coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32345337|t=2020. Is a more aggressive COVID-19 case detection approach mitigating the burden on ICUs? Some reflections from Italy |pdf=|usr=}} | ||
+ | {{tp|p=32345343|t=2020. COVID-19: ICU delirium management during SARS-CoV-2 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32345359|t=2020. The role of telemedicine during the COVID-19 epidemic in China?experience from Shandong province |pdf=|usr=}} | ||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
{{tp|p=32246142|t=ä. Care for the psychological status of frontline medical staff fighting against COVID-19 |pdf=|usr=}} | {{tp|p=32246142|t=ä. Care for the psychological status of frontline medical staff fighting against COVID-19 |pdf=|usr=}} | ||
{{tp|p=32339218|t=ä. Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers |pdf=|usr=}} | {{tp|p=32339218|t=ä. Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers |pdf=|usr=}} | ||
+ | {{tp|p=32295761|t=2020. Mitigating the psychological effects of COVID-19 on health care workers |pdf=|usr=}} | ||
+ | {{tp|p=32375848|t=2020. Psychological stress of ICU nurses in the time of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32220243|t=2020. Special attention to nurses? protection during the COVID-19 epidemic |pdf=|usr=}} | ||
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
{{tp|p=32371559|t=2020. Helping children cope with the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32371559|t=2020. Helping children cope with the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32357996|t=2020. Health care practitioners responsibility to address intimate partner violence related to the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32299225|t=2020. Physical Distancing and Emotional Closeness Amidst COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
Zeile 181: | Zeile 258: | ||
{{tp|p=32344168|t=ä. Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea |pdf=|usr=}} | {{tp|p=32344168|t=ä. Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea |pdf=|usr=}} | ||
{{tp|p=32354669|t=ä. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy |pdf=|usr=}} | {{tp|p=32354669|t=ä. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy |pdf=|usr=}} | ||
+ | {{tp|p=32331805|t=ä. Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32144097|t=2020. What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic?|pdf=|usr=}} | ||
+ | {{tp|p=32269019|t=2020. Social distancing to combat COVID-19: We are all on the front line |pdf=|usr=}} | ||
+ | {{tp|p=32332040|t=2020. What can countries learn from Hong Kong s response to the COVID-19 pandemic?|pdf=|usr=}} | ||
+ | {{tp|p=32269018|t=2020. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada |pdf=|usr=}} | ||
+ | {{tp|p=32355435|t=ä. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections The case of China |pdf=|usr=}} | ||
+ | {{tp|p=32220236|t=2020. Familial cluster of COVID-19 infection from an asymptomatic |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
{{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}} | {{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}} | ||
+ | {{tp|p=32292239|t=2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis |pdf=|usr=}} | ||
*'''[[Failure of executive measures]]''' | *'''[[Failure of executive measures]]''' | ||
Zeile 197: | Zeile 284: | ||
{{tp|p=32360446|t=2020. COVID-19: don t neglect antimicrobial stewardship principles!|pdf=|usr=}} | {{tp|p=32360446|t=2020. COVID-19: don t neglect antimicrobial stewardship principles!|pdf=|usr=}} | ||
{{tp|p=32058086|t=2020. Novel coronavirus: how things are in Wuhan |pdf=|usr=}} | {{tp|p=32058086|t=2020. Novel coronavirus: how things are in Wuhan |pdf=|usr=}} | ||
+ | {{tp|p=32366470|t=2020. Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection |pdf=|usr=}} | ||
+ | {{tp|p=32184199|t=2020. Working together to contain and manage COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32312831|t=2020. Who should wear a face mask? Experts weigh in on Canada s COVID-19 response |pdf=|usr=}} | ||
+ | {{tp|p=32336678|t=2020. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32362721|t=ä. Cyberpsychology research and COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | {{tp|p=32178711|t=2020. Treatment of COVID-19: old tricks for new challenges |pdf=|usr=}} |
Version vom 20. Mai 2020, 15:50 Uhr
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32129843 ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
32129842 ä. A glimpse into the origins of genetic diversity in SARS-CoV-2
32229288 ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32354367 2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?
32188484 2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan
32345311 2020. Clinical determinants for fatality of 44,672 patients with COVID-19
32173725 ä. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
32161968 ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias
32271373 ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia
32375845 2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?
32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
32357997 2020. Coagulopathy associated with COVID-19
32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32357210 ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
32215618 ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
32323704 2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis
32266761 2020. Neurological manifestations in COVID19 caused by SARS-CoV?2
32354654 ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic
32371006 ä. Diarrhea: An underestimated symptom in Coronavirus disease 2019
32360055 ä. Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
32305249 ä. A case of COVID-19 patient with the diarrhea as initial symptom and literature review
32366282 2020. Liver injury in critically ill patients with COVID-19: a case series
32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32327229 2020. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type
32331781 ä. Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT
32355659 ä. The role of 18F-FDG PET for COVID-19 infection: myth versus reality
32295762 2020. Chest CT imaging of an early Canadian case of COVID-19 in a 28-year-old man
32312827 2020. Lung ultrasonography in a woman with COVID-19: This examination could be remote
32375883 2020. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis
32234724 2020. Lung ultrasound findings in a 64-year-old woman with COVID-19
32345353 2020. Lung ultrasound findings in patients with COVID-19 pneumonia
32360444 ä. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP)
32216962 2020. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement
32344166 ä. COVID-19 pandemic?a focused review for clinicians
32216961 2020. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area
32321645 ä. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update
32328954 ä. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice
32321116 2020. COVID-19 Diagnostic and Management Protocol for Pediatric Patients
32350002 2020. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
32312828 2020. Clarifying the role of lung ultrasonography in COVID-19 respiratory disease
32375855 2020. Ethics guidelines on COVID-19 triage?an emerging international consensus
32234064 2020. Covid-19 in China: ten critical issues for intensive care medicine
32188482 2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China
32151274 2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore
32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32357995 2020. Tracheal intubation in patients with COVID-19
32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women
32332039 2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32264922 2020. COVID-19 and the RAAS?a potential role for angiotensin II?
32147731 ä. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS
32227197 ä. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States
32211789 ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area
32240285 ä. First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States ? Maricopa County, Arizona, 2020
32332041 2020. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission
32317275 2020. SARS-CoV-2 infection associated with spontaneous pneumothorax
32251842 ä. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital
32359867 ä. Impact of gender on extent of lung injury in COVID-19
32362344 ä. Association between clinical manifestations and prognosis in patients with COVID-19
32078069 2020. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
32375850 2020. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan
32354360 2020. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
32344167 ä. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study
32305181 ä. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection
32360083 ä. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients
32306288 ä. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
32277367 ä. Rheumatologists? perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
32373721 2020. Low dose lung radiotherapy for COVID-19 pneumonia The rationale for a cost-effective anti-inflammatory treatment
32269021 2020. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
32209231 2020. Computers and viral diseases Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
32264963 2020. A new clinical trial to test high-dose vitamin C in patients with COVID-19
32280433 ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
32345336 2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
32241022 ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection
32297915 ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection
32315026 ä. Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems
32166318 ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response
32354653 ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice
32371561 2020. Pulmonary function testing precautions in a time of COVID-19
32371560 2020. PAP therapy increases the risk of transmission of COVID-19
32252508 2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak
32371164 ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32166310 ä. A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2)
32278082 ä. Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre
32330569 ä. Clinical microbiology laboratory adaptation to COVID-19 emergency: experience at a large teaching hospital in Rome, Italy
32312609 ä. Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described
32299723 ä. Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic
32362444 ä. Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19
32359847 ä. Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing
32354668 ä. Effect of COVID-19 pandemic on cancer clinician decision making: Known knowns and known unknowns
32359846 2020. Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore
32246280 ä. Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China
32078048 ä. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis
32265036 2020. A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic
32291080 ä. Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience
32299617 2020. Respirators and surgical facemasks for COVID-19: implications for MRI
32235170 ä. Triaging Spine Surgery in the COVID-19 Era
32274425 2020. COVID-19: Global radiation oncology?s targeted response for pandemic preparedness
32321117 2020. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
32294673 2020. How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center
32376644 2020. Confronting the COVID-19 surgery crisis: time for transformational change
32152059 2020. Proposed protocol to keep COVID-19 out of hospitals
32269020 2020. Projecting demand for critical care beds during COVID-19 outbreaks in Canada
32317277 2020. Redesign of a rural emergency department to prepare for the COVID-19 pandemic
32336679 2020. Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions
32273245 ä. The COVID-19 pandemic: Important considerations for contact lens practitioners
32359967 ä. Increased risk of ocular injury seen during lockdown due to COVID-19
32336578 ä. Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?
32272172 2020. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
32334933 ä. Contact lens wear during the COVID-19 pandemic
32305289 ä. No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond???
32183864 2020. Safe patient transport for COVID-19
32070391 2020. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China
32264974 2020. Practice of novel method of bedside postpyloric tube placement in patients with coronavirus disease 2019
32345337 2020. Is a more aggressive COVID-19 case detection approach mitigating the burden on ICUs? Some reflections from Italy
32345343 2020. COVID-19: ICU delirium management during SARS-CoV-2 pandemic
32345359 2020. The role of telemedicine during the COVID-19 epidemic in China?experience from Shandong province
32246142 ä. Care for the psychological status of frontline medical staff fighting against COVID-19
32339218 ä. Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers
32295761 2020. Mitigating the psychological effects of COVID-19 on health care workers
32375848 2020. Psychological stress of ICU nurses in the time of COVID-19
32220243 2020. Special attention to nurses? protection during the COVID-19 epidemic
32371559 2020. Helping children cope with the COVID-19 pandemic
32357996 2020. Health care practitioners responsibility to address intimate partner violence related to the COVID-19 pandemic
32299225 2020. Physical Distancing and Emotional Closeness Amidst COVID-19
- Avoiding clinical medicine in other diseases
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
- Educational aspects of the status hygienicus
- Host, vector, one health, atmospheric aspects
- Origin of Covid19
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32266381 ä. PCR Assays Turned Positive in 25 Discharged COVID-19 Patients
32302000 ä. The duration of viral shedding of discharged patients with severe COVID-19
32360448 ä. SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report
32304746 ä. A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs
32344169 ä. A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection
32344168 ä. Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea
32354669 ä. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy
32331805 ä. Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic
32144097 2020. What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic?
32269019 2020. Social distancing to combat COVID-19: We are all on the front line
32332040 2020. What can countries learn from Hong Kong s response to the COVID-19 pandemic?
32269018 2020. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada
32355435 ä. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections The case of China
32220236 2020. Familial cluster of COVID-19 infection from an asymptomatic
32246996 ä. The SARS-CoV-2 epidemic: how the Italian public is being informed
32292239 2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis
- Failure of executive measures
- Political abuse of Covid19
- Lost people
- Lost civilization
- History of covid19 exploration
- Current state of coviki.org
- PubMed selected papers unsorted to be listed in contents topics
- coviki state of development
- misc.
32296817 ä. Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials
32360446 2020. COVID-19: don t neglect antimicrobial stewardship principles!
32058086 2020. Novel coronavirus: how things are in Wuhan
32366470 2020. Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection
32184199 2020. Working together to contain and manage COVID-19
32312831 2020. Who should wear a face mask? Experts weigh in on Canada s COVID-19 response
32336678 2020. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
32362721 ä. Cyberpsychology research and COVID-19
32178711 2020. Treatment of COVID-19: old tricks for new challenges